Johnson & Johnson (JNJ) est une société cotée en bourse dans le Santé secteur, opérant dans le Drug Manufacturers - General secteur d'activité. Le siège social de l'entreprise est situé à New Brunswick, NJ, United States. Le PDG actuel est Joaquin Duato.
JNJ a date d'introduction en bourse 1943-01-02, 138,100 employés à temps plein, cotée sur le NYSE, une capitalisation boursière de $578.62B.
Johnson & Johnson is a global healthcare company focused on innovative pharmaceuticals and medical devices following its 2023 strategic separation of its consumer health business into Kenvue Inc. The company's Innovative Medicine segment develops prescription medications for complex diseases including rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders. Its MedTech segment provides advanced medical technology solutions spanning electrophysiology, neurovascular care, orthopedic implants, surgical systems, and ACUVUE contact lenses. Operating worldwide and headquartered in New Brunswick, New Jersey, Johnson & Johnson serves hospitals, healthcare professionals, wholesalers, and retailers while maintaining its mission of advancing human health since 1886.
